国邦医药(605507.SH)及子公司拟使用不超15亿元的自有资金进行委托理财

Core Viewpoint - Guobang Pharmaceutical (605507.SH) has approved a proposal to use its own funds for entrusted wealth management, with a maximum limit of RMB 1.5 billion [1] Group 1 - The company held its 15th meeting of the second board and the 13th meeting of the second supervisory board on October 16, 2025 [1] - The approved proposal allows the company and its subsidiaries to use up to RMB 1.5 billion of their own funds for entrusted wealth management [1] - The funds can be used on a rolling basis within the approved limit [1]